Lobbying Activity Report

2603-4231

Organization: Sandoz Canada Inc.
Associated registration: 2015-2603-9
Lobbying Activity date: 2020-11-12
Arranged a meeting: Yes
Posted date: 2020-12-06

In-house lobbyists who participated in the lobbying activity: Guillaume Lefebvre
Carmen Pedro
Senior Public Office Holders who were lobbied in this activity: Sue Bouma, Director
Special Authority, Clinical Services & Evaluation, Provincial Health Services Authority

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement, Provincial Health Services Authority

Tijana Fazlagic, Executive Director
Therapeutic Assessment& Access, Provincial Health Services Authority

Mitch Moneo, Assistant deputy minister
Pharmaceutical, Laboratory and Blood Services Division, Provincial Health Services Authority

Derek Tryan, Executive Coordinator
Pharmaceutical, Laboratory & Blood Services Division, Provincial Health Services Authority

Kelly Uyeno, Executive Director
Integrated Health Services Planning & Systems, Provincial Health Services Authority
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Improve regulatory environment and utilization rates for generics and biosimilars.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Finances and Budgets, Health
Raising awareness to government officials about the challenge of drug supply in the context of Covid-19 and post-Covid-19.
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
  • Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health
 
Senior officer who filed this Lobbying Activity Report: Michel Robidoux
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: